- Home
- DMAA vs TKNO Comparison
DMAA vs TKNO Comparison
Compare DMAA & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAA
- TKNO
- Stock Information
- Founded
- DMAA 2024
- TKNO 1996
- Country
- DMAA United States
- TKNO United States
- Employees
- DMAA N/A
- TKNO N/A
- Industry
- DMAA
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- DMAA
- TKNO Health Care
- Exchange
- DMAA NYSE
- TKNO Nasdaq
- Market Cap
- DMAA 340.5M
- TKNO 356.4M
- IPO Year
- DMAA 2025
- TKNO 2021
- Fundamental
- Price
- DMAA $10.19
- TKNO $5.59
- Analyst Decision
- DMAA
- TKNO Buy
- Analyst Count
- DMAA 0
- TKNO 1
- Target Price
- DMAA N/A
- TKNO $5.00
- AVG Volume (30 Days)
- DMAA 62.7K
- TKNO 260.6K
- Earning Date
- DMAA 01-01-0001
- TKNO 08-12-2025
- Dividend Yield
- DMAA N/A
- TKNO N/A
- EPS Growth
- DMAA N/A
- TKNO N/A
- EPS
- DMAA N/A
- TKNO N/A
- Revenue
- DMAA N/A
- TKNO $38,250,000.00
- Revenue This Year
- DMAA N/A
- TKNO $8.73
- Revenue Next Year
- DMAA N/A
- TKNO $16.53
- P/E Ratio
- DMAA N/A
- TKNO N/A
- Revenue Growth
- DMAA N/A
- TKNO 3.79
- 52 Week Low
- DMAA $9.95
- TKNO $1.16
- 52 Week High
- DMAA $10.27
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- DMAA N/A
- TKNO 38.30
- Support Level
- DMAA N/A
- TKNO $5.15
- Resistance Level
- DMAA N/A
- TKNO $5.65
- Average True Range (ATR)
- DMAA 0.00
- TKNO 0.31
- MACD
- DMAA 0.00
- TKNO -0.04
- Stochastic Oscillator
- DMAA 0.00
- TKNO 31.86
About DMAA DRUGS MADE IN AMER ACQUISITION CORP
Drugs Made In America Acquisition Corp is a blank check company.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.